Apellis Pharmaceuticals Inc (APLS) — Cash Flow Reinvestment Rate
Apellis Pharmaceuticals Inc (APLS) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $296.00K (capex $148.00K plus investments $-148.00K) from operating cash flow of $108.47 Million. Explore APLS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apellis Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Apellis Pharmaceuticals Inc across 1 annual periods. Also explore Apellis Pharmaceuticals Inc (APLS) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for Apellis Pharmaceuticals Inc. For live market cap and broader valuation context, see Apellis Pharmaceuticals Inc (APLS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | $313.00K | $45.33 Million | $313.00K | — |